Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2005
04/06/2005EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity
04/06/2005EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
04/06/2005CN1604894A 经取代的苯基衍生物 Substituted phenyl derivatives
04/06/2005CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/06/2005CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/06/2005CN1195751C Thiophen sulfuryl compound
04/06/2005CN1195745C Antiviral macrocyclic compounds
04/06/2005CN1195737C HIV proteinase inhibitor
04/06/2005CN1195522C Benzodiazepine derivatives
04/05/2005US6875894 Electrophilic activity; fluorination, alkylation to nucleophilic compounds
04/05/2005US6875790 Viricides
04/05/2005US6875788 Non-insulin dependent diabetes, antidiabetic agents, dietetics, antilipemic agents, anticholesterol agents, cardiovascular disorders
04/05/2005US6875787 Vision defects; reducing pressure in eyes
04/05/2005US6875777 Compounds
04/05/2005US6875761 Certain 1,3-disubstituted isoquinoline derivatives
04/05/2005US6875760 Glucagon antagonists/inverse agonists
04/05/2005CA2270086C New benzothiophene, benzofuranic and indolic derivatives, their preparation process and pharmaceutical compositions containing them
04/05/2005CA2226671C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
03/2005
03/31/2005WO2005028465A1 Chromene compound
03/31/2005WO2005028447A1 Benzimidazole derivates: preparation and pharmaceutical applications
03/31/2005WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005WO2005028443A2 Protein tyrosine kinase enzyme inhibitors
03/31/2005WO2005028440A1 Novel gamma secretase inhibitors
03/31/2005WO2005027823A2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/31/2005WO2004108133A3 Modulators of vr1 receptor
03/31/2005WO2004073606A3 Sulfonamide derivatives as ppar modulators
03/31/2005US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
03/31/2005US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents
03/31/2005US20050070718 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/31/2005US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease
03/31/2005US20050070712 Pyrimidine derivatives as ghrelin receptor modulators
03/31/2005US20050070710 Triarylamine containing monomers for optoelectronic devices
03/31/2005US20050070706 Antidiabetic agents; obesity; controlling appetite
03/31/2005US20050070598 Using 4-oxot perhydro( furan or pyran)-3-yl carbamoyl derivative; bone disorders; oral disease; antiarthritic agents
03/31/2005US20050070589 Pyrazolyl inhibitors of 15- lipoxygenase
03/31/2005US20050070588 Imidazolyl inhibitors of 15-lipoxygenase
03/31/2005US20050070587 Substituted naphthyl benzothiophene acids
03/31/2005US20050070578 Using hedgehog antagonist; controlling cell differentiation, cell proliferation
03/31/2005US20050070574 Novel compounds
03/31/2005US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors.
03/31/2005US20050070570 6,8-Dimethoxy isoquinoline derivatives; useful in the treatment or alleviation of disorders and conditions associated with, or dependent on membrane potential or conductance of cells in mammals, including humans, such as asthma, cystic fibrosis, obstructive pulmonary disease, convulsions, vascular spasms
03/31/2005US20050070566 Imidazoquinoline derivatives
03/31/2005US20050070562 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/31/2005US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
03/31/2005US20050070535 Antidiabetic agents; obesity; controlling appetite
03/31/2005US20050070534 Non-peptidic NPY Y2 receptor inhibitors
03/31/2005US20050070531 Using such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile to treat cancer and/or autoimmune disorder
03/31/2005US20050070530 Dipeptidyl peptidase inhibitors
03/31/2005US20050070521 Alkyl ether derivatives or salts thereof
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/31/2005CA2551037A1 Novel piperidine derivative
03/31/2005CA2539766A1 Benzimidazole derivates: preparation and pharmaceutical applications
03/31/2005CA2538855A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005CA2538590A1 Novel gamma secretase inhibitors
03/31/2005CA2538381A1 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/30/2005EP1518855A1 Diaminopyrimidinecarboxa mide derivative
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/30/2005EP1517915A2 Prodrugs of excitatory amino acids
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517895A1 8-(biaryl) quinoline pde4 inhibitors
03/30/2005EP1075467B1 Pyrazole derivatives as p-38 map kinase inhibitors
03/30/2005EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders
03/30/2005CN1602313A 铑和铱的络合物 Complexes of rhodium and iridium
03/30/2005CN1602309A Benzothiophenes as adenosine receptor modulators
03/30/2005CN1602308A Thiophene derivatives used as antiviral agent against flavivirus infections
03/30/2005CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872842 Butenyl substituted taxanes
03/29/2005US6872837 Taxanes having a c10 Heterosubstituted acetate substituent
03/29/2005US6872828 Analyzing using peroxy compound
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872717 Pharmacological uses of azetidine derivatives
03/29/2005US6872716 Sexual diosrders; schizophrenia; drug abuse; eating disorders anxiolytic agents
03/29/2005US6872714 Methods to modulate conditions mediated by the CXCR4 receptor
03/29/2005US6872690 Spraying on plants, environment
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2260213C Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
03/24/2005WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors
03/24/2005WO2005026149A1 Pyrrol derivatives with antibacterial activity
03/24/2005WO2005026135A1 Method for the production of 4-(4-aminophenyl)-3-morpholinon
03/24/2005WO2005026129A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
03/24/2005WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor
03/24/2005WO2005026123A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
03/24/2005WO2005025576A1 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
03/24/2005WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
03/24/2005WO2005025293A2 Fused ring heterocycles as potassium channel modulators
03/24/2005WO2005011657A3 Piperazine derivatives and their use as therapeutic agents
03/24/2005WO2005009967A3 Quinolinone derivatives as inhibitors of c-fms kinase
03/24/2005WO2005003101A3 Pyrazine and pyridine derivatives as rho kinase inhibitors
03/24/2005WO2004087050A3 Mitotic kinesin inhibitors
03/24/2005WO2004085421A3 Bioreductively-activated prodrugs
03/24/2005WO2004073619A3 Ccr8 antagonists
03/24/2005WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors
03/24/2005WO2004067510A8 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
03/24/2005WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 523